Endoscopic Evaluation of Upper Gastrointestinal (GI) Mucosal Damage Induced by PL-2200 Versus Aspirin in Healthy Volunteers

Clinical trial NCT00872534 · COMPLETED

Trial details

NCT number: NCT00872534
Sponsor: PLx Pharma
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Upper Gastrointestinal Mucosal Damage

Start date: 2009-01-01
Primary completion: 2009-07-01
Enrollment: 204

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.